Table of Content

1 Biologic Drugs Market Overview
1.1 Biologic Drugs Product Overview
1.2 Biologic Drugs Market Segment by Type
1.2.1 Humira
1.2.2 Remicade
1.2.3 Rituxan
1.2.4 Enbrel
1.2.5 Lantus
1.2.6 Avastin
1.2.7 Herceptin
1.2.8 Others
1.3 Global Biologic Drugs Market Size by Type
1.3.1 Global Biologic Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Biologic Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Biologic Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Biologic Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Biologic Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Biologic Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Biologic Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Biologic Drugs Sales Breakdown by Type (2018-2024)
2 Global Biologic Drugs Market Competition by Company
2.1 Global Top Players by Biologic Drugs Sales (2018-2024)
2.2 Global Top Players by Biologic Drugs Revenue (2018-2024)
2.3 Global Top Players by Biologic Drugs Price (2018-2024)
2.4 Global Top Manufacturers Biologic Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biologic Drugs Market Competitive Situation and Trends
2.5.1 Biologic Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Biologic Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologic Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Biologic Drugs Market
2.8 Key Manufacturers Biologic Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Biologic Drugs Status and Outlook by Region
3.1 Global Biologic Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Biologic Drugs Historic Market Size by Region
3.2.1 Global Biologic Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Biologic Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Biologic Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Biologic Drugs Forecasted Market Size by Region
3.3.1 Global Biologic Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Biologic Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Biologic Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Biologic Drugs by Application
4.1 Biologic Drugs Market Segment by Application
4.1.1 Diabetes
4.1.2 Inflammation
4.1.3 Auto-Immune Diseases
4.1.4 Blood Diseases
4.1.5 Cardiovascular Diseases
4.1.6 Others
4.2 Global Biologic Drugs Market Size by Application
4.2.1 Global Biologic Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Biologic Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Biologic Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Biologic Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Biologic Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Biologic Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Biologic Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Biologic Drugs Sales Breakdown by Application (2018-2024)
5 North America Biologic Drugs by Country
5.1 North America Biologic Drugs Historic Market Size by Country
5.1.1 North America Biologic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Biologic Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Biologic Drugs Sales in Value by Country (2018-2024)
5.2 North America Biologic Drugs Forecasted Market Size by Country
5.2.1 North America Biologic Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Biologic Drugs Sales in Value by Country (2024-2034)
6 Europe Biologic Drugs by Country
6.1 Europe Biologic Drugs Historic Market Size by Country
6.1.1 Europe Biologic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Biologic Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Biologic Drugs Sales in Value by Country (2018-2024)
6.2 Europe Biologic Drugs Forecasted Market Size by Country
6.2.1 Europe Biologic Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Biologic Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Biologic Drugs by Region
7.1 Asia-Pacific Biologic Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Biologic Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Biologic Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Biologic Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Biologic Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Biologic Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Biologic Drugs Sales in Value by Region (2024-2034)
8 Latin America Biologic Drugs by Country
8.1 Latin America Biologic Drugs Historic Market Size by Country
8.1.1 Latin America Biologic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Biologic Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Biologic Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Biologic Drugs Forecasted Market Size by Country
8.2.1 Latin America Biologic Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Biologic Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Biologic Drugs by Country
9.1 Middle East and Africa Biologic Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Biologic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Biologic Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Biologic Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Biologic Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Biologic Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Biologic Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Biologic Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Roche Biologic Drugs Products Offered
10.1.5 Roche Recent Development
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Company Information
10.2.2 Abbott Laboratories Introduction and Business Overview
10.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Abbott Laboratories Biologic Drugs Products Offered
10.2.5 Abbott Laboratories Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Johnson & Johnson Biologic Drugs Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Merck & Co.
10.4.1 Merck & Co. Company Information
10.4.2 Merck & Co. Introduction and Business Overview
10.4.3 Merck & Co. Biologic Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck & Co. Biologic Drugs Products Offered
10.4.5 Merck & Co. Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Biologic Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pfizer Biologic Drugs Products Offered
10.5.5 Pfizer Recent Development
10.6 Amgen
10.6.1 Amgen Company Information
10.6.2 Amgen Introduction and Business Overview
10.6.3 Amgen Biologic Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Amgen Biologic Drugs Products Offered
10.6.5 Amgen Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Biologic Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sanofi Biologic Drugs Products Offered
10.7.5 Sanofi Recent Development
10.8 Novartis
10.8.1 Novartis Company Information
10.8.2 Novartis Introduction and Business Overview
10.8.3 Novartis Biologic Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Novartis Biologic Drugs Products Offered
10.8.5 Novartis Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Biologic Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Eli Lilly Biologic Drugs Products Offered
10.9.5 Eli Lilly Recent Development
10.10 Amgen
10.10.1 Amgen Company Information
10.10.2 Amgen Introduction and Business Overview
10.10.3 Amgen Biologic Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Amgen Biologic Drugs Products Offered
10.10.5 Amgen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Biologic Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Biologic Drugs Industrial Chain Analysis
11.4 Biologic Drugs Market Dynamics
11.4.1 Biologic Drugs Industry Trends
11.4.2 Biologic Drugs Market Drivers
11.4.3 Biologic Drugs Market Challenges
11.4.4 Biologic Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Biologic Drugs Distributors
12.3 Biologic Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Humira
Table 2. Major Company of Remicade
Table 3. Major Company of Rituxan
Table 4. Major Company of Enbrel
Table 5. Major Company of Lantus
Table 6. Major Company of Avastin
Table 7. Major Company of Herceptin
Table 8. Major Company of Others
Table 9. Global Biologic Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Biologic Drugs Sales by Type (2018-2024) & (K Units)
Table 11. Global Biologic Drugs Sales Market Share in Volume by Type (2018-2024)
Table 12. Global Biologic Drugs Sales by Type (2018-2024) & (US& Million)
Table 13. Global Biologic Drugs Market Share in Value by Type (2018-2024)
Table 14. Global Biologic Drugs Price by Type (2018-2024) & (USD/Unit)
Table 15. Global Biologic Drugs Sales by Type (2024-2034) & (K Units)
Table 16. Global Biologic Drugs Sales Market Share in Volume by Type (2024-2034)
Table 17. Global Biologic Drugs Sales by Type (2024-2034) & (US$ Million)
Table 18. Global Biologic Drugs Sales Market Share in Value by Type (2024-2034)
Table 19. Global Biologic Drugs Price by Type (2024-2034) & (USD/Unit)
Table 20. North America Biologic Drugs Sales by Type (2018-2024) & (K Units)
Table 21. North America Biologic Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Europe Biologic Drugs Sales (K Units) by Type (2018-2024)
Table 23. Europe Biologic Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Asia-Pacific Biologic Drugs Sales (K Units) by Type (2018-2024)
Table 25. Asia-Pacific Biologic Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Latin America Biologic Drugs Sales (K Units) by Type (2018-2024)
Table 27. Latin America Biologic Drugs Sales by Type (2018-2024) & (US$ Million)
Table 28. Middle East and Africa Biologic Drugs Sales (K Units) by Type (2018-2024)
Table 29. Middle East and Africa Biologic Drugs Sales by Type (2018-2024) & (US$ Million)
Table 30. Global Biologic Drugs Sales by Company (2018-2024) & (K Units)
Table 31. Global Biologic Drugs Sales Share by Company (2018-2024)
Table 32. Global Biologic Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 33. Global Biologic Drugs Revenue Share by Company (2018-2024)
Table 34. Global Market Biologic Drugs Price by Company (2018-2024) & (USD/Unit)
Table 35. Global Biologic Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 36. Global Biologic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 37. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologic Drugs as of 2022)
Table 38. Date of Key Manufacturers Enter into Biologic Drugs Market
Table 39. Key Manufacturers Biologic Drugs Product Type
Table 40. Mergers & Acquisitions, Expansion Plans
Table 41. Global Biologic Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 42. Global Biologic Drugs Sales by Region (2018-2024) & (K Units)
Table 43. Global Biologic Drugs Sales Market Share in Volume by Region (2018-2024)
Table 44. Global Biologic Drugs Sales by Region (2018-2024) & (US$ Million)
Table 45. Global Biologic Drugs Sales Market Share in Value by Region (2018-2024)
Table 46. Global Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 47. Global Biologic Drugs Sales by Region (2024-2034) & (K Units)
Table 48. Global Biologic Drugs Sales Market Share in Volume by Region (2024-2034)
Table 49. Global Biologic Drugs Sales by Region (2024-2034) & (US$ Million)
Table 50. Global Biologic Drugs Sales Market Share in Value by Region (2024-2034)
Table 51. Global Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 52. Global Biologic Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 53. Global Biologic Drugs Sales by Application (2018-2024) & (K Units)
Table 54. Global Biologic Drugs Sales Market Share in Volume by Application (2018-2024)
Table 55. Global Biologic Drugs Sales by Application (2018-2024) & (US$ Million)
Table 56. Global Biologic Drugs Sales Market Share in Value by Application (2018-2024)
Table 57. Global Biologic Drugs Price by Application (2018-2024) & (USD/Unit)
Table 58. Global Biologic Drugs Sales by Application (2024-2034) & (K Units)
Table 59. Global Biologic Drugs Sales Market Share in Volume by Application (2024-2034)
Table 60. Global Biologic Drugs Sales by Application (2024-2034) & (US$ Million)
Table 61. Global Biologic Drugs Sales Market Share in Value by Application (2024-2034)
Table 62. Global Biologic Drugs Price by Application (2024-2034) & (USD/Unit)
Table 63. North America Biologic Drugs Sales by Application (2018-2024) (K Units)
Table 64. North America Biologic Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Europe Biologic Drugs Sales by Application (2018-2024) (K Units)
Table 66. Europe Biologic Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Asia-Pacific Biologic Drugs Sales by Application (2018-2024) (K Units)
Table 68. Asia-Pacific Biologic Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. Latin America Biologic Drugs Sales by Application (2018-2024) (K Units)
Table 70. Latin America Biologic Drugs Sales by Application (2018-2024) & (US$ Million)
Table 71. Middle East and Africa Biologic Drugs Sales by Application (2018-2024) (K Units)
Table 72. Middle East and Africa Biologic Drugs Sales by Application (2018-2024) & (US$ Million)
Table 73. North America Biologic Drugs Sales by Country (2018-2024) & (K Units)
Table 74. North America Biologic Drugs Sales Market Share in Volume by Country (2018-2024)
Table 75. North America Biologic Drugs Sales by Country (2018-2024) & (US$ Million)
Table 76. North America Biologic Drugs Sales Market Share in Value by Country (2018-2024)
Table 77. North America Biologic Drugs Sales by Country (2024-2034) & (K Units)
Table 78. North America Biologic Drugs Sales Market Share in Volume by Country (2024-2034)
Table 79. North America Biologic Drugs Sales by Country (2024-2034) & (US$ Million)
Table 80. North America Biologic Drugs Sales Market Share in Value by Country (2024-2034)
Table 81. Europe Biologic Drugs Sales by Country (2018-2024) & (K Units)
Table 82. Europe Biologic Drugs Sales Market Share in Volume by Country (2018-2024)
Table 83. Europe Biologic Drugs Sales by Country (2018-2024) & (US$ Million)
Table 84. Europe Biologic Drugs Sales Market Share in Value by Country (2018-2024)
Table 85. Europe Biologic Drugs Sales by Country (2024-2034) & (K Units)
Table 86. Europe Biologic Drugs Sales Market Share in Volume by Country (2024-2034)
Table 87. Europe Biologic Drugs Sales by Country (2024-2034) & (US$ Million)
Table 88. Europe Biologic Drugs Sales Market Share in Value by Country (2024-2034)
Table 89. Asia-Pacific Biologic Drugs Sales by Region (2018-2024) & (K Units)
Table 90. Asia-Pacific Biologic Drugs Sales Market Share in Volume by Region (2018-2024)
Table 91. Asia-Pacific Biologic Drugs Sales by Region (2018-2024) & (US$ Million)
Table 92. Asia-Pacific Biologic Drugs Sales Market Share in Value by Region (2018-2024)
Table 93. Asia-Pacific Biologic Drugs Sales by Region (2024-2034) & (K Units)
Table 94. Asia-Pacific Biologic Drugs Sales Market Share in Volume by Region (2024-2034)
Table 95. Asia-Pacific Biologic Drugs Sales by Region (2024-2034) & (US$ Million)
Table 96. Asia-Pacific Biologic Drugs Sales Market Share in Value by Region (2024-2034)
Table 97. Latin America Biologic Drugs Sales by Country (2018-2024) & (K Units)
Table 98. Latin America Biologic Drugs Sales Market Share in Volume by Country (2018-2024)
Table 99. Latin America Biologic Drugs Sales by Country (2018-2024) & (US$ Million)
Table 100. Latin America Biologic Drugs Sales Market Share in Value by Country (2018-2024)
Table 101. Latin America Biologic Drugs Sales by Country (2024-2034) & (K Units)
Table 102. Latin America Biologic Drugs Sales Market Share in Volume by Country (2024-2034)
Table 103. Latin America Biologic Drugs Sales by Country (2024-2034) & (US$ Million)
Table 104. Latin America Biologic Drugs Sales Market Share in Value by Country (2024-2034)
Table 105. Middle East and Africa Biologic Drugs Sales by Country (2018-2024) & (K Units)
Table 106. Middle East and Africa Biologic Drugs Sales Market Share in Volume by Country (2018-2024)
Table 107. Middle East and Africa Biologic Drugs Sales by Country (2018-2024) & (US$ Million)
Table 108. Middle East and Africa Biologic Drugs Sales Market Share in Value by Country (2018-2024)
Table 109. Middle East and Africa Biologic Drugs Sales by Country (2024-2034) & (K Units)
Table 110. Middle East and Africa Biologic Drugs Sales Market Share in Volume by Country (2024-2034)
Table 111. Middle East and Africa Biologic Drugs Sales by Country (2024-2034) & (US$ Million)
Table 112. Middle East and Africa Biologic Drugs Sales Market Share in Value by Country (2024-2034)
Table 113. Roche Company Information
Table 114. Roche Introduction and Business Overview
Table 115. Roche Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Roche Biologic Drugs Product
Table 117. Roche Recent Development
Table 118. Abbott Laboratories Company Information
Table 119. Abbott Laboratories Introduction and Business Overview
Table 120. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Abbott Laboratories Biologic Drugs Product
Table 122. Abbott Laboratories Recent Development
Table 123. Johnson & Johnson Company Information
Table 124. Johnson & Johnson Introduction and Business Overview
Table 125. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Johnson & Johnson Biologic Drugs Product
Table 127. Johnson & Johnson Recent Development
Table 128. Merck & Co. Company Information
Table 129. Merck & Co. Introduction and Business Overview
Table 130. Merck & Co. Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Merck & Co. Biologic Drugs Product
Table 132. Merck & Co. Recent Development
Table 133. Pfizer Company Information
Table 134. Pfizer Introduction and Business Overview
Table 135. Pfizer Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Pfizer Biologic Drugs Product
Table 137. Pfizer Recent Development
Table 138. Amgen Company Information
Table 139. Amgen Introduction and Business Overview
Table 140. Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Amgen Biologic Drugs Product
Table 142. Amgen Recent Development
Table 143. Sanofi Company Information
Table 144. Sanofi Introduction and Business Overview
Table 145. Sanofi Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Sanofi Biologic Drugs Product
Table 147. Sanofi Recent Development
Table 148. Novartis Company Information
Table 149. Novartis Introduction and Business Overview
Table 150. Novartis Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Novartis Biologic Drugs Product
Table 152. Novartis Recent Development
Table 153. Eli Lilly Company Information
Table 154. Eli Lilly Introduction and Business Overview
Table 155. Eli Lilly Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Eli Lilly Biologic Drugs Product
Table 157. Eli Lilly Recent Development
Table 158. Amgen Company Information
Table 159. Amgen Introduction and Business Overview
Table 160. Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Amgen Biologic Drugs Product
Table 162. Amgen Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Biologic Drugs Market Trends
Table 166. Biologic Drugs Market Drivers
Table 167. Biologic Drugs Market Challenges
Table 168. Biologic Drugs Market Restraints
Table 169. Biologic Drugs Distributors List
Table 170. Biologic Drugs Downstream Customers
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologic Drugs Product Picture
Figure 2. Global Biologic Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Biologic Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Biologic Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Humira
Figure 6. Global Humira Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Remicade
Figure 8. Global Remicade Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Rituxan
Figure 10. Global Rituxan Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Enbrel
Figure 12. Global Enbrel Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Lantus
Figure 14. Global Lantus Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Avastin
Figure 16. Global Avastin Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Product Picture of Herceptin
Figure 18. Global Herceptin Sales YoY Growth (2018-2034) & (K Units)
Figure 19. Product Picture of Others
Figure 20. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 21. Global Biologic Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 22. Global Biologic Drugs Sales Market Share by Type in 2022 & 2034
Figure 23. North America Biologic Drugs Sales Market Share in Volume by Type in 2022
Figure 24. North America Biologic Drugs Sales Market Share in Value by Type in 2022
Figure 25. Europe Biologic Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Europe Biologic Drugs Sales Market Share in Value by Type in 2022
Figure 27. Asia-Pacific Biologic Drugs Sales Market Share in Volume by Type in 2022
Figure 28. Asia-Pacific Biologic Drugs Sales Market Share in Value by Type in 2022
Figure 29. Latin America Biologic Drugs Sales Market Share in Volume by Type in 2022
Figure 30. Latin America Biologic Drugs Sales Market Share in Value by Type in 2022
Figure 31. Middle East and Africa Biologic Drugs Sales Market Share in Volume by Type in 2022
Figure 32. Middle East and Africa Biologic Drugs Sales Market Share in Value by Type in 2022
Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Biologic Drugs Sales in 2022
Figure 34. The 5 and 10 Largest Manufacturers in the World: Market Share by Biologic Drugs Revenue in 2022
Figure 35. Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Product Picture of Diabetes
Figure 37. Global Diabetes Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Inflammation
Figure 39. Global Inflammation Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Product Picture of Auto-Immune Diseases
Figure 41. Global Auto-Immune Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 42. Product Picture of Blood Diseases
Figure 43. Global Blood Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 44. Product Picture of Cardiovascular Diseases
Figure 45. Global Cardiovascular Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 46. Product Picture of Others
Figure 47. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 48. Global Biologic Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 49. Global Biologic Drugs Sales Market Share by Application in 2022 & 2034
Figure 50. North America Biologic Drugs Sales Market Share in Volume by Application in 2022
Figure 51. North America Biologic Drugs Sales Market Share in Value by Application in 2022
Figure 52. Europe Biologic Drugs Sales Market Share in Volume by Application in 2022
Figure 53. Europe Biologic Drugs Sales Market Share in Value by Application in 2022
Figure 54. Asia-Pacific Biologic Drugs Sales Market Share in Volume by Application in 2022
Figure 55. Asia-Pacific Biologic Drugs Sales Market Share in Value by Application in 2022
Figure 56. Latin America Biologic Drugs Sales Market Share in Volume by Application in 2022
Figure 57. Latin America Biologic Drugs Sales Market Share in Value by Application in 2022
Figure 58. Middle East and Africa Biologic Drugs Sales Market Share in Value by Application in 2022
Figure 59. Key Raw Materials Price
Figure 60. Biologic Drugs Manufacturing Cost Structure
Figure 61. Biologic Drugs Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed